Cleared Traditional

K122783 - PLASMAFIT ACETABULAR CUP AND VITELENE INSERT

K122783 is an FDA 510(k) clearance for PLASMAFIT ACETABULAR CUP AND VITELENE I..., manufactured by Aesculap Implant System, Inc.. The device is a Class 2 Orthopedic device with product code OQG cleared through the Traditional 510(k) pathway after a 414-day FDA review.

K122783 · Aesculap Implant System, Inc. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2013
Decision
414d
Days
Class 2
Risk

K122783 is an FDA 510(k) clearance for the PLASMAFIT ACETABULAR CUP AND VITELENE INSERT. Classified as Hip Prosthesis, Semi-constrained, Cemented, Metal/polymer, + Additive, Porous, Uncemented (product code OQG), Class II - Special Controls.

Submitted by Aesculap Implant System, Inc. (Center Valley, US). The FDA issued a Cleared decision on October 30, 2013 after a review of 414 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3358 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Orthopedic submissions.

View all Aesculap Implant System, Inc. devices

FDA 510(k) Submission Details - K122783

510(k) Number K122783 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 11, 2012
Decision Date October 30, 2013
Days to Decision 414 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
292d slower than avg
Panel avg: 122d · This submission: 414d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

OQG Device Classification - Class 2, Special Controls

Product Code OQG Hip Prosthesis, Semi-constrained, Cemented, Metal/polymer, + Additive, Porous, Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3358
Definition 1. Non-inflammatory Degenerative Joint Disease Including Osteoarthritis And Avascular Necrosis. 2. Rheumatoid Arthritis. 3. Correction Of Functional Deformity. 4. Treatment Of Non-union, Femoral Neck Fracture, And Trochanteric Fractures Of The Proximal Femur With Head Involvement, Unmanageable By Other Techniques. 5. Revision Procedures Where Other Treatment Or Devices Have Failed. Cemented And Uncemented Use.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - OQG Hip Prosthesis, Semi-constrained, Cemented, Metal/polymer, + Additive, Porous, Uncemented

All 19
Devices cleared under the same product code (OQG) and FDA review panel - the closest regulatory comparables to K122783.
KLASSIC HD ACETABULAR INSERT WITH E-LINK POLY
K141972 · Total Joint Orthopedics, Inc. · Oct 2014
NOVOHIP BIPOLAR HEAD/NOVOHIP VITAMIN E LINER/ BONE SCREWS/ HOLE PLUG
K140701 · Novosource, Inc. · Jun 2014
VITALITE E CROSS-LINKED POLYETHYLENE ACETABULAR INSERT
K130652 · Consensus Orthopedics, Inc. · Dec 2013
X-ALT HIGHLY CROSS LINKED VE ACETABULAR LINER
K130365 · Encore Medical, L.P. · Sep 2013
PBP TOTAL HIP SYSTEM
K122158 · Pipeline Biomedical Products, LLC · Dec 2012
CROSS-OVER ACETABULAR SHELL & LINER
K122773 · Stelkast Company · Oct 2012